Investigation on the expression of basophil CD63, CD203C and FcεRI in the overlap of asthma and chronic obstructive pulmonary disease
返回论文页
|更新时间:2023-04-16
|
Investigation on the expression of basophil CD63, CD203C and FcεRI in the overlap of asthma and chronic obstructive pulmonary disease
Journal of Chongqing Medical UniversityVol. 47, Issue 9, Pages: 1012-1017(2022)
作者机构:
锦州医科大学附属第三医院呼吸科,锦州,121002
作者简介:
基金信息:
DOI:
CLC:R562
Published:2022,
扫 描 看 全 文
Zhang Yujiao. Investigation on the expression of basophil CD63, CD203C and FcεRI in the overlap of asthma and chronic obstructive pulmonary disease. [J]. Journal of Chongqing Medical University 47(9):1012-1017(2022)
DOI:
Zhang Yujiao. Investigation on the expression of basophil CD63, CD203C and FcεRI in the overlap of asthma and chronic obstructive pulmonary disease. [J]. Journal of Chongqing Medical University 47(9):1012-1017(2022)DOI:
Investigation on the expression of basophil CD63, CD203C and FcεRI in the overlap of asthma and chronic obstructive pulmonary disease
Objective: To investigate the relationship between the expression level of basophil surface molecules in patients with asthma-chronic obstructive pulmonary disease overlap (ACO) in acute period and in remission period. Methods: Totally 32 healthy people and respectively 14 cases of acute and remission ACO patients admitted to The Third Affiliated Hospital of Jinzhou Medical University were collected in the study. By collecting the venous blood from the elbow
the basophils were obtained by flow cytometry using three gating strategies. In order to compare the expression levels of basophil surface molecules (CD63
CD203c
FcεRI) between patients and healthy groups at different stages
the results and disease states were retrospectively studied. Results: The Mean fluorescence intensity (MFI) of CD63 in acute basophil was significantly different from that in healthy group (P<0.05)
and there was no significant difference in CD203c and FcεRI in acute basophil compared with that in healthy group. The MFI of CD63 and FcεRI in the remission phase was significantly different from that in the healthy group (P<0.05)
and the MFI of CD203c in the remission phase was not significantly different from that in the healthy group (P>0.05). There were no significant differences in the MFI of CD63
CD203c and FcεRI in the basophil between the acute phase and the remission phase. The MFI of CCR3+
CCR3+/CD123+HLA-DR- and CD123+HLA-DR- in acute and remission stages was significantly different from that in healthy groups (P<0.001). Conclusion: The expression of CD63 and FcεRI on the surface of basophil in the ACO patients is enhanced
suggesting that basophil is involved in the pathogenesis of ACO
and the detection of its surface molecular expression is suggestive to the judgment of ACO condition.
Research progress of autophagy in lung inflammatory diseases
Expressions of FcεRI and CD63 in eosinophils of patients with allergic rhinitis
Research progress in the diagnosis and treatment of non-eosinophilic asthma
Causality between nasal diseases and COPD: a two-sample Mendelian randomization analysis
Gastroesophageal reflux disease causes an increased risk of chronic obstructive pulmonary disease: a two-sample bidirectional Mendelian randomization study
Related Author
Duan Yushan
Liu Qiong
Wang Zhao
Chen Dong
Zang Yanyan
He Shaoheng
Zhang Huiyun
Zhang Xinyue
Related Institution
Department of Emergency and Critical Care Medicine,The First Affiliated Hospital of Chongqing Medical University
Allergy and Clinical Immunology Research Center,The First Affiliated Hospital of Jinzhou Medical University
Department of Respiratory Medicine,Children’s Hospital,Zhejiang University School of Medicine/ National Clinical Research Center for Child Health
Department of Pediatrics,The Affiliated Hospital of Nanjing University of Chinese Medicine,The First Clinical Medical College of Nanjing University of Chinese Medicine
Department of Traditional Chinese Medicine,Children’s Hospital,Zhejiang University School of Medicine/ National Clinical Research Center for Child Health